MTOR and Parkinson disease: We show that AMPK activity negatively correlates with both mTOR activity and α-syn pathology in primary neurons, suggesting AMPK activation as a potential therapeutic strategy in PD capable of normalizing cellular metabolism, reducing neuropathology, or both.